US5167811AExpiredUtility

Affinity chromatography using dried calcium alginate-magnetite separation media in a magnetically stabilized fluidized bed

46
Assignee: UNIV PENNSYLVANIAPriority: Nov 28, 1984Filed: Mar 4, 1992Granted: Dec 1, 1992
Est. expiryNov 28, 2004(expired)· nominal 20-yr term from priority
B01J 20/3251B01J 20/3204B01D 15/3804C12N 11/10B01D 15/3809B01J 20/286C07K 14/765B01J 20/3092G01N 33/553B01J 2220/54B01J 20/3253B01J 20/3274B01J 2220/4812B01J 20/3293C12N 11/14B01D 15/1807B01J 20/06B01J 20/28011B01J 2220/58B01J 20/28009B01J 20/3255
46
PatentIndex Score
10
Cited by
22
References
7
Claims

Abstract

Disclosed is a method of conducting affinity chromatographic separations of biomaterials which comprises contacting the biomaterial with a solid support comprising a generally spherical bead having a generally central magnetic core and a surrounding exterior coat about the core comprising a material capable of binding with the biomaterial.

Claims

exact text as granted — not AI-modified
We claim: 
     
       1. A method for the manufacture of a mechanically rigid and generally spherical bead having an interior generally comprising a magnetically susceptible material having low residual magnetiziation, and an exterior generally comprising a material capable of binding with bioproduct materials, wherein said bead has low residual magnetization, a rough surface structure, a diameter at least about 200 μm., and a porosity of less than about 5% when in a dried state, comprising the steps of: admixing an alginate solution with a plurality of particles which comprise a magnetically susceptible material having low residual magnetization; and   cross-linking the alginate acid residues of said alginate solution into a gel to form said bead; and   drying said bead.   
     
     
       2. The method of claim 1 wherein the alginate solution is prepared from sodium alginate. 
     
     
       3. The method of claim 1 wherein the particles comprise magnetite. 
     
     
       4. The method of claim 1 wherein the cross-linking agent comprises calcium ions. 
     
     
       5. The method of claim 1 further comprising attaching a binding ligand to the cross-linked support material. 
     
     
       6. The method of claim 5 wherein the ligand is a triazine dye. 
     
     
       7. The method of claim 5 wherein the ligand is a an antibody.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.